MBX 2109

Drug identity checked against registry records

Also recorded as Canvuparatide

A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.

Included trials

TrialSponsorPhaseStatusPrimary completion
Safety, Pharmacokinetics and Efficacy of MBX 2109 in Patients With HypoparathyroidismNCT06465108MBX BiosciencesPhase 2Completed2025-05-23Actual

Regulatory dates and decisions

No regulatory events match this view.This does not mean no FDA events have occurred.